Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 1.7 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Agribio Spirits Ltd reported standalone revenue from operations of Rs. 782.98 lakhs for Q3 FY26, nearly flat compared to Rs. 784.80 lakhs in Q3 FY25. For the nine-month period (9M FY26), standalone revenue surged to Rs. 3,204.81 lakhs from Rs. 1,347.76 lakhs in 9M FY25, a jump of roughly 138%, likely reflecting a change in business mix after the company's transformation into a spirits business. Standalone profit after tax for 9M FY26 rose modestly to Rs. 99.32 lakhs (from Rs. 81.92 lakhs), with basic EPS of Rs. 0.91. On a consolidated basis (including share of profit from associate Agribiotech Industries Ltd), 9M FY26 PAT was Rs. 315.79 lakhs vs Rs. 300.77 lakhs, and consolidated EPS was Rs. 2.90. The auditor (M/s RP Khandelwal & Associates) issued an unmodified limited review report. The company also acquired a 99.10% stake in Solkit Distillery and Brewery Pvt. Ltd. in Sept 2025, which has not yet started operations, and a merger with Agribiotech Industries remains pending approvals.
Strong top-line growth on a nine-month basis reflects the ongoing business transformation into spirits, but profitability gains remain modest and Q3 standalone PAT dipped slightly, suggesting margin pressures. Shareholders should watch for the pending merger approval with Agribiotech Industries and the eventual start of operations at the newly acquired Solkit subsidiary, both of which could materially impact future results.